|
|
||||||||
J Biol Chem, Vol. 274, Issue 27, 18902-18908, July 2, 1999
From CCR5 is the major coreceptor for
macrophage-tropic human immunodeficiency virus type I (HIV-1). For most
G-protein-coupled receptors that have been tested so far, the disulfide
bonds linking together the extracellular loops (ECL) are required for
maintaining the structural integrity necessary for ligand binding and
receptor activation. A natural mutation affecting
Cys20, which is thought to form a disulfide bond with
Cys269, has been described in various human populations,
although the consequences of this mutation for CCR5 function are not
known. Using site-directed mutagenesis, we mutated the four
extracellular cysteines of CCR5 singly or in combination to investigate
their role in maintaining the structural conformation of the receptor, its ligand binding and signal transduction properties, and its ability
to function as a viral coreceptor. Alanine substitution of any single
Cys residue reduced surface expression levels by 40-70%. However,
mutation of Cys101 or Cys178, predicted to link
ECL1 and ECL2 of the receptor, abolished recognition of CCR5 by a panel
of conformation sensitive anti-CCR5 antibodies. The effects of the
mutations on receptor expression and conformation were partially
temperature-sensitive, with partial restoration of receptor expression
and conformation achieved by incubating cells at 32 °C. All cysteine
mutants were unable to bind detectable levels of MIP-1
Extracellular Cysteines of CCR5 Are Required for Chemokine
Binding, but Dispensable for HIV-1 Coreceptor Activity
,
,
,
,
,
**,
Institut de Recherche Interdisciplinaire,
** Service de Génétique Médicale, and
Euroscreen, Université Libre de Bruxelles, Campus Erasme,
808 route de Lennik, B-1070 Bruxelles, Belgium and the
¶ Department of Pathology and Laboratory Medicine, University of
Pennsylvania, Philadelphia, Pennsylvania 19104
, and did not
respond functionally to CCR5 agonists. Surprisingly, all cysteine
mutants did support infection by R5 strains of HIV, though at reduced
levels. These results indicate that both disulfide bonds of CCR5 are
necessary for maintaining the structural integrity of the receptor
necessary for ligand binding and signaling. Env binding and the
mechanisms of HIV entry appear much less sensitive to alterations of
CCR5 conformation.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Jin, X. Shen, B. R. Baggett, X. Kong, and P. J. LiWang The Human CC Chemokine MIP-1beta Dimer Is Not Competent to Bind to the CCR5 Receptor J. Biol. Chem., September 21, 2007; 282(38): 27976 - 27983. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Maeda, D. Das, H. Ogata-Aoki, H. Nakata, T. Miyakawa, Y. Tojo, R. Norman, Y. Takaoka, J. Ding, G. F. Arnold, et al. Structural and Molecular Interactions of CCR5 Inhibitors with CCR5 J. Biol. Chem., May 5, 2006; 281(18): 12688 - 12698. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Golding, S. Khurana, F. Yarovinsky, L. R. King, G. Abdoulaeva, L. Antonsson, C. Owman, E. J. Platt, D. Kabat, J. F. Andersen, et al. CCR5 N-terminal Region Plays a Critical Role in HIV-1 Inhibition by Toxoplasma gondii-derived Cyclophilin-18 J. Biol. Chem., August 19, 2005; 280(33): 29570 - 29577. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khurana, M. Kennedy, L. R. King, and H. Golding Identification of a Linear Peptide Recognized by Monoclonal Antibody 2D7 Capable of Generating CCR5-Specific Antibodies with Human Immunodeficiency Virus-Neutralizing Activity J. Virol., June 1, 2005; 79(11): 6791 - 6800. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. El-Asmar, J.-Y. Springael, S. Ballet, E. U. Andrieu, G. Vassart, and M. Parmentier Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers Mol. Pharmacol., February 1, 2005; 67(2): 460 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Datta and M. J. Stone Soluble mimics of a chemokine receptor: Chemokine binding by receptor elements juxtaposed on a soluble scaffold Protein Sci., November 1, 2003; 12(11): 2482 - 2491. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanpain, B. J. Doranz, A. Bondue, C. Govaerts, A. De Leener, G. Vassart, R. W. Doms, A. Proudfoot, and M. Parmentier The Core Domain of Chemokines Binds CCR5 Extracellular Domains while Their Amino Terminus Interacts with the Transmembrane Helix Bundle J. Biol. Chem., February 7, 2003; 278(7): 5179 - 5187. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Govaerts, A. Bondue, J.-Y. Springael, M. Olivella, X. Deupi, E. Le Poul, S. J. Wodak, M. Parmentier, L. Pardo, and C. Blanpain Activation of CCR5 by Chemokines Involves an Aromatic Cluster between Transmembrane Helices 2 and 3 J. Biol. Chem., January 10, 2003; 278(3): 1892 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Paterlini Structure Modeling of the Chemokine Receptor CCR5: Implications for Ligand Binding and Selectivity Biophys. J., December 1, 2002; 83(6): 3012 - 3031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Farzan, S. Chung, W. Li, N. Vasilieva, P. L. Wright, C. E. Schnitzler, R. J. Marchione, C. Gerard, N. P. Gerard, J. Sodroski, et al. Tyrosine-sulfated Peptides Functionally Reconstitute a CCR5 Variant Lacking a Critical Amino-terminal Region J. Biol. Chem., October 18, 2002; 277(43): 40397 - 40402. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Basmaciogullari, G. J. Babcock, D. Van Ryk, W. Wojtowicz, and J. Sodroski Identification of Conserved and Variable Structures in the Human Immunodeficiency Virus gp120 Glycoprotein of Importance for CXCR4 Binding J. Virol., October 2, 2002; 76(21): 10791 - 10800. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chelli and M. Alizon Determinants of the trans-Dominant Negative Effect of Truncated Forms of the CCR5 Chemokine Receptor J. Biol. Chem., December 7, 2001; 276(50): 46975 - 46982. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanpain, R. Buser, C. A. Power, M. Edgerton, C. Buchanan, M. Mack, G. Simmons, P. R. Clapham, M. Parmentier, and A. E. I. Proudfoot A chimeric MIP-1{alpha}/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors J. Leukoc. Biol., June 1, 2001; 69(6): 977 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanpain, B. Lee, M. Tackoen, B. Puffer, A. Boom, F. Libert, M. Sharron, V. Wittamer, G. Vassart, R. W. Doms, et al. Multiple nonfunctional alleles of CCR5 are frequent in various human populations Blood, September 1, 2000; 96(5): 1638 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kuhmann, E. J. Platt, S. L. Kozak, and D. Kabat Cooperation of Multiple CCR5 Coreceptors Is Required for Infections by Human Immunodeficiency Virus Type 1 J. Virol., August 1, 2000; 74(15): 7005 - 7015. [Abstract] [Full Text] |
||||
![]() |
D. J. Chabot, H. Chen, D. S. Dimitrov, and C. C. Broder N-Linked Glycosylation of CXCR4 Masks Coreceptor Function for CCR5-Dependent Human Immunodeficiency Virus Type 1 Isolates J. Virol., May 1, 2000; 74(9): 4404 - 4413. [Abstract] [Full Text] |
||||
![]() |
H. H. Ho, D. Du, and M. C. Gershengorn The N Terminus of Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Is Necessary for High Affinity Chemokine Binding but Not for Constitutive Activity J. Biol. Chem., October 29, 1999; 274(44): 31327 - 31332. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Chabot and C. C. Broder Substitutions in a Homologous Region of Extracellular Loop 2 of CXCR4 and CCR5 Alter Coreceptor Activities for HIV-1 Membrane Fusion and Virus Entry J. Biol. Chem., July 28, 2000; 275(31): 23774 - 23782. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Govaerts, C. Blanpain, X. Deupi, S. Ballet, J. A. Ballesteros, S. J. Wodak, G. Vassart, L. Pardo, and M. Parmentier The TXP Motif in the Second Transmembrane Helix of CCR5. A STRUCTURAL DETERMINANT OF CHEMOKINE-INDUCED ACTIVATION J. Biol. Chem., April 13, 2001; 276(16): 13217 - 13225. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanpain, V. Wittamer, J.-M. Vanderwinden, A. Boom, B. Renneboog, B. Lee, E. Le Poul, L. El Asmar, C. Govaerts, G. Vassart, et al. Palmitoylation of CCR5 Is Critical for Receptor Trafficking and Efficient Activation of Intracellular Signaling Pathways J. Biol. Chem., June 22, 2001; 276(26): 23795 - 23804. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rebres, L. E. Vaz, J. M. Green, and E. J. Brown Normal Ligand Binding and Signaling by CD47 (Integrin-associated Protein) Requires a Long Range Disulfide Bond between the Extracellular and Membrane-spanning Domains J. Biol. Chem., September 7, 2001; 276(37): 34607 - 34616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Vila-Coro, M. Mellado, A. Martin de Ana, P. Lucas, G. del Real, C. Martinez-A., and J. M. Rodriguez-Frade HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization PNAS, March 28, 2000; 97(7): 3388 - 3393. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanpain, J.-M. Vanderwinden, J. Cihak, V. Wittamer, E. Le Poul, H. Issafras, M. Stangassinger, G. Vassart, S. Marullo, D. Schlondorff, et al. Multiple Active States and Oligomerization of CCR5 Revealed by Functional Properties of Monoclonal Antibodies Mol. Biol. Cell, February 1, 2002; 13(2): 723 - 737. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |